研究
教育
解決策
サインイン
JA
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
TR - Turkish
JA - Japanese
Eaton Peabody Laboratories,
Department of Otolaryngology,
Eaton Peabody Laboratories, Department of Otolaryngology
Sonam Dilwali has not added Biography.
If you are Sonam Dilwali and would like to personalize this page please email our Author Liaison for assistance.
Sporadic vestibular schwannomas associated with good hearing secrete higher levels of fibroblast growth factor 2 than those associated with poor hearing irrespective of tumor size.
Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology Jun, 2013 | Pubmed ID: 23512073
Mining immune epitopes in the inner ear.
Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery Mar, 2014 | Pubmed ID: 24367049
Aspirin intake correlates with halted growth of sporadic vestibular schwannoma in vivo.
Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology Feb, 2014 | Pubmed ID: 24448296
Primary culture of human Schwann and schwannoma cells: improved and simplified protocol.
Hearing research Sep, 2014 | Pubmed ID: 24910344
Nonsteroidal anti-inflammatory medications are cytostatic against human vestibular schwannomas.
Translational research : the journal of laboratory and clinical medicine Jul, 2015 | Pubmed ID: 25616959
Interplay between VEGF-A and cMET signaling in human vestibular schwannomas and schwann cells.
Cancer biology & therapy , 2015 | Pubmed ID: 25692621
Preclinical validation of anti-nuclear factor-kappa B therapy to inhibit human vestibular schwannoma growth.
Molecular oncology Aug, 2015 | Pubmed ID: 25891780
Secreted Factors from Human Vestibular Schwannomas Can Cause Cochlear Damage.
Scientific reports Dec, 2015 | Pubmed ID: 26690506
Extracellular vesicles derived from human vestibular schwannomas associated with poor hearing damage cochlear cells.
Neuro-oncology Nov, 2016 | Pubmed ID: 27194145
Massachusetts Eye and Ear
Harvard Program in Speech and Hearing Bioscience and Technology
Harvard Medical School
Lukas D. Landegger1,2,3,
Sonam Dilwali1,4,
Konstantina M. Stankovic1,2,4
1Eaton Peabody Laboratories, Department of Otolaryngology, Massachusetts Eye and Ear,
2Department of Otolaryngology, Harvard Medical School,
3Department of Otolaryngology, Vienna General Hospital, Medical University of Vienna,
4, Harvard Program in Speech and Hearing Bioscience and Technology
Lukas D. Landegger*,1,2,3,
Jessica E. Sagers*,1,4,
Takeshi Fujita1,2,
Mehmet I. Sahin1,2,
4Program in Speech and Hearing Bioscience and Technology, Harvard Medical School
個人情報保護方針
利用規約
一般データ保護規則
お問い合わせ
図書館への推薦
JoVE ニュースレター
JoVE Journal
メソッドコレクション
JoVE Encyclopedia of Experiments
アーカイブ
JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
教員向けリソースセンター
著者
図書館員
アクセス
JoVEについて
Copyright © 2023 MyJoVE Corporation. All rights reserved